Spring direct naar de hoofdnavigatie of de inhoud
‘To explore, together with a client, how the best IP protection can be obtained is for me the logical next step after an invention has been made.’
Frits Michiels

Frits Michiels

  • Life Sciences
  • European and Dutch Patent Attorney
  • Valuation specialist
  • Partner

Frits Michiels has had an extensive scientific career in both knowledge institutes and biotech companies. From 2004, he was employed as IP manager at Galapagos Genomics BV and subsequently also at other Dutch biotech startups, such as Agendia and Merus. He has worked for V.O. since 2006.

Continue reading

He is specialized in biochemistry, molecular biology, cell biology, diagnostics, signal transduction, and medical biotechnology. His clients are primarily knowledge institutes and start ups. He is involved in patent prosecution and strategic advice.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Merus (2006)
  • Galapagos Genomics (1999-2005)
  • Senior Scientist at the Netherlands Cancer Institute (1994-1998)
  • Post-Doc, Amsterdam Medical Center (1991-1993)
  • PhD research at Max Planck Institute for Biochemistry, Munich (1985-1990)

Education

  • PhD in Genetics, Radboud University Nijmegen (1990)
  • MSc in Microbiology, Radboud University Nijmegen (1984)

Publications

  • Michiels, GAM Damages extended to after termination of a tort. MIP Vol 205: 94-95 (2011)
  • JP ten Klooster, EE Evers, L Janssen, LM Machesky, F Michiels, P Hordijk and JG Collard. Biochem J. 397, 39–45 (2006)
  • GJ Arts, E Langemeijer, R Tissingh, L Ma, H Pavliska, K Dokic, R Dooijes, E Mesić, R Clasen, F Michiels, J van der Schueren, M Lambrecht, S Herman, R Brys, K Thys, M Hoffmann, P Tomme, H van Es. Genome Res 13, 2325-32 (2003)
  • A Malliri, RA van der Kammen, K Clark, M van der Valk, F Michiels & JG Collard. Nature 417, 867-871 (2002)
  • F Michiels et al. Nature Biotech 20, 1154-1157 (2002)
  • R Engers, E Springer, F Michiels, JG Collard, HE Gabbert. J Biol Chem 276, 41889-97 (2001)
  • WO2002057463 Swap/counter selection; a rapid cloning
  • WO2002070744 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds method
  • WO2005124342 Methods and means for treatment of osteoarthritis

Languages

  • English
  • Dutch
  • German

Also see these experts

More experts

News

Recommended by JUVE Patent

In late September, V.O. received a ‘recommendation’ from JUVE Patent in the Patent Filing and Litigation: Patent Attorneys categories for the second year in a row. Mentioned as ‘recommended individuals’ are Jetze Beeksma, Marco Box, Leo Jessen, Martin Klok, Bernard Ledeboer and Otto Oudshoorn.Continue reading

Column – ‘Choose what you want to protect’

Traditionally, the Triumph and Sloggi brands have been known for their innovations in the lingerie market. The Triumph Group always wants to be in the lead when it comes to its expertise in comfort, style and fit of lingerie.Continue reading

Registered as European Patent Attorneys

In July, no less than five associates of V.O. were registered as European patent attorneys, after having learned a few weeks earlier that they had all passed their EQE (European Qualifying Examination).Continue reading

Events

IP Service World 2022

Holiday Inn Munich - City Centre, an IHG Hotel, Hochstraße, München, Germany

Europe’s largest IP Convention & Trade Fair, the IP Service World, is a very unique event. It is the perfect mixture of a comprehensive trade fair and a top-class convention with contributions from leading experts. Continue reading

Dutch Life Sciences Conference – 24 November 2022

CORPUS Congress Centre, Willem Einthovenstraat, Oegstgeest, Netherlands

The 18th edition of the Dutch Life Sciences conference, the foremost life sciences business network event in the Netherlands. Continue reading